Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Lack of Effectiveness of Intravenous High-Dose Methotrexate for Prevention of CNS Relapse in Patients with High-Risk DLBCL: A Retrospective Analysis from Alberta, Canada

Robert Puckrin, MD, Haidar El Darsa, MD, Sunita Ghosh, PhD P Stat, Anthea Peters, MSc, MD FRCPC, Douglas A. Stewart, MD FRCPC

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-139025

Published: 2020

Journal Articles

Significant Adverse Consequences of Initial Watchful Waiting for Follicular Lymphoma Patients: A Retrospective Analysis of Patients Diagnosed in Alberta from 1994-2011

Gwynivere Davies, MDFRCPC, Sunita Ghosh, PhD P Stat, Danielle Oh, MD, Mita Manna, MD FRCPC, Anthea Peters, MSc, MD FRCPC, Colin Stewart, Douglas A. Stewart

Blood (2017) 130 (Supplement 1): 4041.

https://doi.org/10.1182/blood.V130.Suppl_1.4041.4041

Published: 2017

Journal Articles

Use of Tyrosine Kinase Inhibitors Post-Allogeneic Stem Cell Transplant in Patients with Philadelphia or BCR-ABL Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis

Elena Liew, MD, Sunita Ghosh, PhD, P.Stat., Lalit Saini, MD

Blood (2016) 128 (22): 2778.

https://doi.org/10.1182/blood.V128.22.2778.2778

Published: 2016

Journal Articles

Development of Second Primary Malignancies in Multiple Myeloma Patients Treated with Lenalidomide: An Alberta Perspective

Katherine Fung, BSP, ACPR, Peter Duggan, MD FRCPC, Carole Chambers, BScPharm, MBA, FCSHP, FISOPP, Patrick Shui-Lun Yau, BPharm, Deonne Dersch-Mills, BScPharm, ACPR, PharmD, Frances Cusano, BScPharm, ACPR, Nizar J Bahlis, Sunita Ghosh, PhD, P.Stat.

Blood (2016) 128 (22): 4528.

https://doi.org/10.1182/blood.V128.22.4528.4528

Published: 2016

Journal Articles

Myeloablative Allogeneic Stem Cell Transplantation in CLL: A Single Centre Retrospective Study

Sonia Cerquozzi, MD FRCPC, Sunita Ghosh, PhD, P.Stat., Diana Quinlan, Amy Trottier, MD, Mary Lynn Savoie, MD FRCPC, Douglas A. Stewart, MD FRCPC, James A. Russell, MD FRCPC, Carolyn Owen, MD MDes (UK), FRCPC

Blood (2015) 126 (23): 5530.

https://doi.org/10.1182/blood.V126.23.5530.5530

Published: 2015

Journal Articles

Population Based Analysis of Outcomes of Primary Central Nervous System Lymphoma (PCNSL) Suggests a Treatment Strategy Including Intensive Chemotherapy with Autologous Stem Cell Transplantation Provides a Survival Advantage for Patients <65 Years of Age

Joanna Graczyk, MD FRCPC, Sunita Ghosh, PhD, Neil Chua, MD FRCPC, Douglas A. Stewart, MD FRCPC, Carolyn J. Owen, MD FRCPC

Blood (2014) 124 (21): 2520.

https://doi.org/10.1182/blood.V124.21.2520.2520

Published: 2014

Journal Articles

Aggressive Non-Hodgkin Lymphoma: Predictive Value Of Sarcopenia and Skeletal Muscle Density On Prognosis With Rituximab Containing Therapy

Michael P Chu, MD, Jessica Lieffers, Andrew R Belch, MD, Neil Chua, MD, FRCPC, Amelie Fontaine, MD, Randeep Sangha, A. Robert Turner, MD, FRCPC, Sunita Ghosh, PhD, Michael Sawyer, MD

Blood (2013) 122 (21): 3023.

https://doi.org/10.1182/blood.V122.21.3023.3023

Published: 2013

Journal Articles

Indolent Non-Hodgkin Lymphoma: Skeletal Muscle Density Predicts Overall Survival With Rituximab Based Chemotherapy

Michael P Chu, MD, Jessica Lieffers, Andrew R Belch, MD, Neil Chua, MD, FRCPC, Amelie Fontaine, MD, Randeep Sangha, A. Robert Turner, MD, Sunita Ghosh, PhD, Michael Sawyer, MD

Blood (2013) 122 (21): 5078.

https://doi.org/10.1182/blood.V122.21.5078.5078

Published: 2013

Journal Articles

Functional and Familial Risk of B Lineage Malignancies in Patients Carrying Single Nucleotide Polymorphisms (SNPs) in the Hyaluronan Synthase 1 Gene (HAS1),

Linda M. Pilarski, PhD, Hemalatha Kuppusamy, Jitra Kriangkum, PhD, Amanda Warkentin, Sunita Ghosh, PhD, Spencer B Gibson, PhD, Hlif Steingrimsdottir, MD, Vilhelmina Haraldsdottir, MD, James B Johnston, MD, FRCPC, Helga M Ogmundsdottir, MD, PhD, Andrew R Belch, MD

Blood (2011) 118 (21): 3930.

https://doi.org/10.1182/blood.V118.21.3930.3930

Published: 2011

NARROW

Lack of Effectiveness of Intravenous High-Dose Methotrexate for Prevention of CNS Relapse in Patients with High-Risk DLBCL: A Retrospective Analysis from Alberta, Canada

Significant Adverse Consequences of Initial Watchful Waiting for Follicular Lymphoma Patients: A Retrospective Analysis of Patients Diagnosed in Alberta from 1994-2011

Use of Tyrosine Kinase Inhibitors Post-Allogeneic Stem Cell Transplant in Patients with Philadelphia or BCR-ABL Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis

Development of Second Primary Malignancies in Multiple Myeloma Patients Treated with Lenalidomide: An Alberta Perspective

Myeloablative Allogeneic Stem Cell Transplantation in CLL: A Single Centre Retrospective Study

Population Based Analysis of Outcomes of Primary Central Nervous System Lymphoma (PCNSL) Suggests a Treatment Strategy Including Intensive Chemotherapy with Autologous Stem Cell Transplantation Provides a Survival Advantage for Patients <65 Years of Age

Aggressive Non-Hodgkin Lymphoma: Predictive Value Of Sarcopenia and Skeletal Muscle Density On Prognosis With Rituximab Containing Therapy

Indolent Non-Hodgkin Lymphoma: Skeletal Muscle Density Predicts Overall Survival With Rituximab Based Chemotherapy

Functional and Familial Risk of B Lineage Malignancies in Patients Carrying Single Nucleotide Polymorphisms (SNPs) in the Hyaluronan Synthase 1 Gene (HAS1),

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only